Rwanda, German drug maker sign deal to boost access to health products
Thursday, May 14, 2026
Minister of State for Health Yvan Butera and Dr. Claus Runge, Chief Health Equity Officer at Bayer AG during the signing ceremonin in Kigali on Thursday, May 14. Courtesy

The Ministry of Health has signed a Manufacturing and Supply Agreement with German pharmaceutical company Bayer AG to improve access to quality health products and strengthen public health supply systems.

The agreement was signed in Kigali by the Minister of State for Health Dr Yvan Butera and Dr. Claus Runge, Bayer AG's Chief Health Equity Officer on Thursday, May 14.

Both delegations pose for a group photo during the signing ceremony in Kigali on Thursday, May 14. Courtesy

This comes a month after the Ministry of Health signed an agreement with Swiss pharmaceutical company Sandoz Group AG aimed at ensuring a stable supply of essential medicines, including antibiotics and cancer treatments.

Under the agreement, Sandoz will directly manufacture and supply around 60 key medicines to Rwanda, with the possibility of expanding the range and reach in the future.

The partnership aims to strengthen reliable access to quality health products, reinforce public health supply systems, and support sustainable health care delivery.

The new deals are part of ongoing efforts to improve access to affordable medicines in Rwanda and African countries.